Cargando…

Interaction of Anticancer Drugs with Human Organic Anion Transporter hOAT4

Human organic anion transporter 4 (hOAT4) belongs to a family of multispecific organic anion transporters that play critical roles in the disposition of numerous drugs and therefore are the major sites for drug-drug interaction. Drug-drug interactions contribute significantly to the individual varia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chenchang, Zhang, Jinghui, You, Guofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421026/ https://www.ncbi.nlm.nih.gov/pubmed/30941173 http://dx.doi.org/10.1155/2019/1951786

Ejemplares similares

Oral Proteasomal Inhibitors Ixazomib, Oprozomib, and Delanzomib Upregulate the Function of Organic Anion Transporter 3 (OAT3): Implications in OAT3-Mediated Drug-Drug Interactions
por: Fan, Yunzhou, et al.
Publicado: (2021)

Entecavir Interacts with Influx Transporters hOAT1, hCNT2, hCNT3, but Not with hOCT2: The Potential for Renal Transporter-Mediated Cytotoxicity and Drug–Drug Interactions
por: Mandíková, Jana, et al.
Publicado: (2016)

Polymorphisms of SLC22A9 (hOAT7) in Korean Females with Osteoporosis
por: Ahn, Seong Kyu, et al.
Publicado: (2015)

AG490, a JAK2-specific inhibitor, downregulates the expression and activity of organic anion transporter-3
por: Zhang, Jinghui, et al.
Publicado: (2018)

Protein kinase C regulates organic anion transporter 1 through phosphorylating ubiquitin ligase Nedd4–2
por: Yu, Zhou, et al.
Publicado: (2021)

Perfluoroalkyl substances (PFASs) are substrates of the renal human organic anion transporter 4 (OAT4)
por: Louisse, Jochem, et al.
Publicado: (2022)

Acamprosate Is a Substrate of the Human Organic Anion Transporter (OAT) 1 without OAT3 Inhibitory Properties: Implications for Renal Acamprosate Secretion and Drug–Drug Interactions
por: Antonescu, Irina E., et al.
Publicado: (2020)

Transport of Kynurenic Acid by Rat Organic Anion Transporters rOAT1 and rOAT3: Species Difference between Human and Rat in OAT1
por: Uwai, Yuichi, et al.
Publicado: (2013)

Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes
por: Wu, Wei, et al.
Publicado: (2017)

Organic anion transporters, OAT1 and OAT3, are crucial biopterin transporters involved in bodily distribution of tetrahydrobiopterin and exclusion of its excess
por: Ohashi, Akiko, et al.
Publicado: (2017)

Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma
por: Whisenant, Thomas C., et al.
Publicado: (2022)

Insulin-like growth factor 1 modulates the phosphorylation, expression, and activity of organic anion transporter 3 through protein kinase A signaling pathway
por: Zhang, Jinghui, et al.
Publicado: (2020)

Organic Anion and Cation SLC22 “Drug” Transporter (Oat1, Oat3, and Oct1) Regulation during Development and Maturation of the Kidney Proximal Tubule
por: Gallegos, Thomas F., et al.
Publicado: (2012)

Pharmacokinetics of gallic acid and protocatechuic acid in humans after dosing with Relinqing (RLQ) and the potential for RLQ-perpetrated drug–drug interactions on organic anion transporter (OAT) 1/3
por: Li, Ziqiang, et al.
Publicado: (2021)

Chloroquine and Hydroxychloroquine, as Proteasome Inhibitors, Upregulate the Expression and Activity of Organic Anion Transporter 3
por: Liang, Zhengxuan, et al.
Publicado: (2023)

Cilastatin protects against imipenem-induced nephrotoxicity via inhibition of renal organic anion transporters (OATs)
por: Huo, Xiaokui, et al.
Publicado: (2019)

Male-Dominant Activation of Rat Renal Organic Anion Transporter 1 (Oat1) and 3 (Oat3) Expression by Transcription Factor BCL6
por: Wegner, Waja, et al.
Publicado: (2012)

Arsenic and Mercury Containing Traditional Chinese Medicine (Realgar and Cinnabar) Strongly Inhibit Organic Anion Transporters, Oat1 and Oat3, In Vivo in Mice
por: Yu, Wen-Hao, et al.
Publicado: (2015)

Estrogen receptor α (ERα) indirectly induces transcription of human renal organic anion transporter 1 (OAT1)
por: Euteneuer, Anna M., et al.
Publicado: (2019)

Involvement of Organic Anion Transporters in the Pharmacokinetics and Drug Interaction of Rosmarinic Acid
por: Kang, Yun Ju, et al.
Publicado: (2021)

Molecular basis for selective uptake and elimination of organic anions in the kidney by OAT1
por: Parker, Joanne L., et al.
Publicado: (2023)

The involvement of human organic anion transporting polypeptides (OATPs) in drug-herb/food interactions
por: Ali, Youmna, et al.
Publicado: (2020)

Organic anion transporters also mediate the drug–drug interaction between imipenem and cilastatin
por: Zhu, Yanna, et al.
Publicado: (2020)

Impaired Insulin Signaling Affects Renal Organic Anion Transporter 3 (Oat3) Function in Streptozotocin-Induced Diabetic Rats
por: Lungkaphin, Anusorn, et al.
Publicado: (2014)

Overview of organic anion transporters and organic anion transporter polypeptides and their roles in the liver
por: Li, Ting-Ting, et al.
Publicado: (2019)

Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat
por: Lepist, Eve-Irene, et al.
Publicado: (2014)

Retraction: Impaired Insulin Signaling Affects Renal Organic Anion Transporter 3 (Oat3) Function in Streptozotocin-Induced Diabetic Rats
Publicado: (2018)

P-glycoprotein- and organic anion-transporting polypeptide-mediated transport of periplocin may lead to drug–herb/drug–drug interactions
por: Liang, Sheng, et al.
Publicado: (2014)

Coordinate regulation of systemic and kidney tryptophan metabolism by the drug transporters OAT1 and OAT3
por: Granados, Jeffry C., et al.
Publicado: (2021)

Drug transporters OAT1 and OAT3 have specific effects on multiple organs and gut microbiome as revealed by contextualized metabolic network reconstructions
por: Jamshidi, Neema, et al.
Publicado: (2022)

Overview of the Anticancer Profile of Avenanthramides from Oat
por: Turrini, Eleonora, et al.
Publicado: (2019)

Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions
por: Karlgren, Maria, et al.
Publicado: (2012)

JBP485, A Dual Inhibitor of Organic Anion Transporters (OATs) and Renal Dehydropeptidase-I (DHP-I), Protects Against Imipenem-Induced Nephrotoxicity
por: Wang, Chong, et al.
Publicado: (2022)

Evaluation of Chinese-Herbal-Medicine-Induced Herb-Drug Interactions: Focusing on Organic Anion Transporter 1
por: Lin, Chang-Ching, et al.
Publicado: (2012)

Assessment of the Role of Renal Organic Anion Transporters in Drug-Induced Nephrotoxicity
por: Hagos, Yohannes, et al.
Publicado: (2010)

Regulation of organic anion transport in the liver.
por: Roelofsen, H., et al.
Publicado: (1997)

Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide
por: Jeong, Hyeon-Uk, et al.
Publicado: (2015)

Characteristic and Mechanism of Drug-Herb Interaction Between Acetylsalicylic Acid and Danhong Injection Mediated by Organic Anion Transporters
por: Li, Jianping, et al.
Publicado: (2020)

Scutellarin is Highly Likely to be Responsible for Drug-Drug Interactions Mediated by Hepatic Organic Anion-Transporting Polypeptide1B3
por: Liu, Jianming, et al.
Publicado: (2020)

Bile Acid–Drug Interaction via Organic Anion-Transporting Polypeptide 4C1 Is a Potential Mechanism of Altered Pharmacokinetics of Renally Excreted Drugs
por: Yamauchi, Minami, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jenfb9rh8huhra6hbafpnthkbl